Literature DB >> 10839736

Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction.

M Maass1, J Jahn, J Gieffers, K Dalhoff, H A Katus, W Solbach.   

Abstract

Because individual diagnoses of vascular infection with Chlamydia pneumoniae depend entirely on surgically removed tissues, a better assay to predict vascular infection is needed. Polymerase chain reaction detection of chlamydial DNA was applied to CD14-positive cells collected from 238 patients with angiographically identified unstable angina or acute myocardial infarction. C. pneumoniae was detected in 52 (28%) of 188 persons with unstable angina and in 13 (26%) of 50 persons with myocardial infarction. Differences between groups were not significant. C. pneumoniae is present in monocytes/macrophages of a significant proportion of persons with progressive coronary artery disease. Infarction is not accompanied by a rise in chlamydial detection rates. The potential role of chlamydiae in coronary atherosclerosis may therefore be more related to acceleration of disease or systemic effects by persistent infection than to sudden initiation of infarction by acute infection.

Entities:  

Mesh:

Year:  2000        PMID: 10839736     DOI: 10.1086/315610

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion.

Authors:  Hideaki Ikejima; Herman Friedman; German F Leparc; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

6.  Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.

Authors:  Maria Lucia C Tondella; Deborah F Talkington; Brian P Holloway; Scott F Dowell; Karyn Cowley; Montse Soriano-Gabarro; Mitchell S Elkind; Barry S Fields
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.

Authors:  E Podsiadły; J Przyłuski; A Kwiatkowski; M Kruk; M Wszoła; R Nosek; W Rowiński; W Ruzyłło; S Tylewska-Wierzbanowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

8.  Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.

Authors:  Corinna Hermann; Kathrin Graf; Annemarie Groh; Eberhard Straube; Thomas Hartung
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.

Authors:  Alessandra Ciervo; Paolo Visca; Andrea Petrucca; Luigi Maria Biasucci; Attilio Maseri; Antonio Cassone
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

10.  Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.

Authors:  Marek Smieja; James Mahony; Astrid Petrich; Jens Boman; Max Chernesky
Journal:  BMC Infect Dis       Date:  2002-10-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.